Goldman Sachs Group Inc. Raises Stock Position in KORU Medical Systems, Inc. $KRMD

Key Points

• Goldman Sachs Group Inc. increased its stake in KORU Medical Systems by 189.5%, holding approximately 242,781 shares valued at $617,000 by the end of the first quarter.
• Institutional investors, including HighTower Advisors and Jane Street Group, also raised their positions in KORU Medical Systems, indicating a growing interest in the company.
• KORU Medical Systems reported a quarterly earnings per share of $0.01, surpassing analysts' expectations, with revenue of $10.20 million, exceeding the consensus estimate of $9.46 million.

Goldman Sachs Group Inc. boosted its position in shares of KORU Medical Systems, Inc. (NASDAQ:KRMD - Free Report) by 189.5% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 242,781 shares of the company's stock after purchasing an additional 158,914 shares during the period. Goldman Sachs Group Inc. owned approximately 0.53% of KORU Medical Systems worth $617,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. HighTower Advisors LLC raised its stake in shares of KORU Medical Systems by 18.4% in the 1st quarter. HighTower Advisors LLC now owns 51,400 shares of the company's stock valued at $131,000 after acquiring an additional 8,000 shares during the period. Northern Trust Corp raised its stake in shares of KORU Medical Systems by 11.2% in the 4th quarter. Northern Trust Corp now owns 79,175 shares of the company's stock valued at $305,000 after acquiring an additional 7,967 shares during the period. Millennium Management LLC raised its stake in shares of KORU Medical Systems by 4.5% in the 4th quarter. Millennium Management LLC now owns 283,710 shares of the company's stock valued at $1,092,000 after acquiring an additional 12,187 shares during the period. Connor Clark & Lunn Investment Management Ltd. raised its stake in shares of KORU Medical Systems by 11.8% in the 1st quarter. Connor Clark & Lunn Investment Management Ltd. now owns 66,917 shares of the company's stock valued at $170,000 after acquiring an additional 7,046 shares during the period. Finally, Jane Street Group LLC raised its stake in shares of KORU Medical Systems by 67.0% in the 4th quarter. Jane Street Group LLC now owns 68,923 shares of the company's stock valued at $265,000 after acquiring an additional 27,664 shares during the period. 58.60% of the stock is owned by hedge funds and other institutional investors.

KORU Medical Systems Price Performance

KORU Medical Systems stock opened at $3.95 on Thursday. The company's 50 day simple moving average is $3.90 and its 200-day simple moving average is $3.25. The company has a market capitalization of $182.65 million, a price-to-earnings ratio of -43.89 and a beta of 0.57. KORU Medical Systems, Inc. has a 1 year low of $1.86 and a 1 year high of $5.05. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.25 and a current ratio of 2.91.

KORU Medical Systems (NASDAQ:KRMD - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The company reported $0.01 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.03) by $0.04. The business had revenue of $10.20 million for the quarter, compared to the consensus estimate of $9.46 million. KORU Medical Systems had a negative net margin of 12.24% and a negative return on equity of 26.77%. As a group, equities research analysts expect that KORU Medical Systems, Inc. will post -0.13 earnings per share for the current year.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.